CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT SECRETS

Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors from the central nervous system, conolidine modulates alternate molecular targets. A Science Advancements review identified that conolidine interacts While using the atypical chemokine receptor ACKR3/CX